Equities and debt securities in a non-TINA environment are competing directly for the flow of capital -- and one gains only by robbing from the other.
A real-world study finds Mounjaro up to three times more effective than Ozempic for weight loss, but some AEs were similar between the two.
Patients taking Mounjaro were 76% more likely to lose at least 5% of their body weight, more than twice as likely to lose at least 10%, and more than three ...
Overweight or obese adults lost more weight and shed pounds faster using Eli Lilly's Mounjaro than those taking Novo Nordisk's popular rival weight loss ...
Novo Nordisk stock skidded Tuesday after Eli Lilly's weight-loss drug outperformed Novo's rival medication in a first-of-its-kind study.
Overweight and obese adults who took the injected medication Mounjaro lost more weight and were more likely to meet specific weight loss targets than people ...
WEDNESDAY, Nov. 29, 2023 (Healthday News) -- The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a ...
Overweight and obese patients on Mounjaro lost, on average, 8.3% of their body weight compared to 6.2% of individuals taking Ozempic, a study suggests.
Researchers discovered that patients using Mounjaro had "significantly larger reductions in body weight" than those on Ozempic.
The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report.
A new diabetes medication being prescribed off-label for weight loss is already experiencing shortages, just weeks after becoming available in Australia.
Recently launched diabetes med with weight loss hype another victim of 'larger than expected demand' Mounjaro, the hotly anticipated competitor to social ...